|Bid||76.19 x 1200|
|Ask||76.31 x 1100|
|Day's Range||74.85 - 76.45|
|52 Week Range||52.04 - 77.23|
|Beta (5Y Monthly)||0.81|
|PE Ratio (TTM)||12.60|
|Earnings Date||Feb. 16, 2021|
|Forward Dividend & Yield||2.00 (2.62%)|
|Ex-Dividend Date||Jan. 21, 2021|
|1y Target Est||84.40|
A former Arkansas health official is sounding alarms about the pace of coronavirus vaccines being administered to residents of long-term care facilities under a U.S. plan that puts major pharmacy chains CVS and Walgreens in charge of many of the shots. Fewer than 10% of doses allocated to those Arkansas seniors have been administered, according to the state health department. The two pharmacies are working with about 40% of the state's facilities.
Many U.S. pharmacies, including those inside Kroger Co supermarkets and the drugstore chain of CVS Health Corp, say they will not be checking IDs before administering COVID-19 vaccines, leaving the door open to those who do not meet states' guidelines to jump the line. While the United States has distributed more than 30 million vaccine doses, a little over 11 million had been administered as of Thursday, a lag that prompted U.S. health secretary Alex Azar to call on states to begin vaccinating the vulnerable older population and those with certain chronic health conditions to get more vaccines into arms. U.S. retailers face a choice of strictly enforcing state eligibility rules with on-site identity checks, or rely on an honor system that could allow people to ignore those guidelines but also get more people inoculated.
CVS Health (CVS) closed the most recent trading day at $75.05, moving +0.17% from the previous trading session.